Venglustat: A Brain-Penetrant GCS Inhibitor for GBA-Mutant Parkinson’s Disease

venglustat

potential BIC oral GCS inhibitor Ph. III in genetic diseases (15 mg QD) brain-penetrant, allosteric inhibitor Scientific Reports Sanofi

Drug Hunter Team